CELOSIDE 100MG ING

About

Celoside 100mg Injection contains a topoisomerase II inhibitor, an antineoplastic agent that plays a crucial role in cancer chemotherapy. Its mechanism of action involves forming a ternary complex with topoisomerase II and DNA, which prevents the re-ligation of DNA strands after they have been cleaved. This leads to an accumulation of DNA strand breaks, ultimately inhibiting DNA synthesis and causing cell cycle arrest in the G2 and S phases. This disruption of DNA integrity and replication triggers apoptosis in rapidly proliferating cancer cells.

Administered intravenously, Celoside is widely used in the treatment of various hematologic malignancies and solid tumors. It is often given in combination with other chemotherapeutic agents to achieve synergistic effects. Due to its myelosuppressive properties, close monitoring of blood counts is essential during treatment. The drug is primarily metabolized in the liver and excreted renally, necessitating careful consideration of patient's liver and kidney function to optimize dosing and minimize toxicity.

Uses

• Treatment of small cell lung cancer
• Management of testicular cancer
• Therapy for non-Hodgkin lymphoma
• Used in acute myeloid leukemia

Directions For Use

Celoside 100mg Injection is administered intravenously by a healthcare professional. The infusion rate and duration are carefully controlled to minimize the risk of hypotension.

Benefits

• Effectively inhibits DNA synthesis in cancer cells
• Induces apoptosis by causing DNA strand breaks
• A key component in many curative chemotherapy regimens
• Can lead to significant tumor response and remission
• Versatile in treating both solid tumors and hematologic cancers
• Contributes to improved survival rates in specific malignancies

Side Effects

• Myelosuppression (neutropenia, thrombocytopenia, anemia)
• Nausea and vomiting
• Alopecia (hair loss)
• Hypotension (during rapid infusion)
• Anorexia
• Diarrhea
• Oral mucositis
• Fatigue
• Peripheral neuropathy (less common)
• Allergic reactions (rash, fever)
• Liver enzyme elevations
• Secondary malignancies (e.g., AML, rare)

Safety Measures

• Alcohol - Avoid alcohol during Celoside treatment as it may exacerbate gastrointestinal side effects and liver toxicity.
• Pregnancy - Celoside is teratogenic and contraindicated in pregnancy. Use effective contraception during and for a period after treatment.
• Breastfeeding - Breastfeeding is not recommended during Celoside therapy due to potential excretion in breast milk and harm to the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary due to altered metabolism and increased toxicity.
• Kidney - Dose reduction is required for patients with moderate to severe renal impairment (CrCl < 50 mL/min) to prevent drug accumulation.
• Lung - Monitor for pulmonary toxicity, including interstitial lung disease, though rare, especially in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.